India rifampicin market is expected
to grow at a steady rate during the forecast period. Rifampicin is a semisynthetic
antibiotic produced from Streptomyces, used to treat several types of bacterial
infections. The India Rifampicin market is driven by increasing number of drug developments. Moreover, rifampicin
is widely used to for the treatment of tuberculosis which is forecasted to
positively influence the market growth. Ongoing research and developmental investments
by key market players is further expected to boost the growth of India Rifampicin
market through FY2026.
The India rifampicin market
is segmented based on source,
form, route of administration, distribution channel, application, end user, company, and region. Based
on application, the market can be segmented into tuberculosis, leprosy,
legionnaire's disease, others. Among these, tuberculosis segment is expected to
dominate in the market over the coming years on account of high prevalence of
tuberculosis in the country. Also, the efficient use of this drug for the
treatment of tuberculosis and tuberculosis-related mycobacterial infections, is
further bolstering the market growth.
The major players operating
in the India rifampicin market are Indian Drugs and Pharmaceuticals Ltd., Cadila
Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Lupin Laboratories Ltd.,
Concept Pharmaceuticals Ltd., Novartis India Ltd., Zydus Cadila Healthcare
Ltd., Themis Pharmaceuticals Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Taurus
Laboratories Pvt. Ltd., and others. Major companies are developing advanced
technologies and launching new products in order to stay competitive in the
market. Other competitive strategies include mergers & acquisitions and new
product developments to expand their geographic reach and to increase their
customer basis.
Years considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the
Study:
- To analyze and estimate the market size of India
rifampicin market from FY2016 to FY2019.
- To estimate and forecast the market size of India
rifampicin market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India rifampicin market
based on source, form, route of administration, distribution channel,
application, end user, company, and regional distribution.
- To identify dominant region or segment in the India
rifampicin market.
- To identify drivers and challenges for India rifampicin
market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in India
rifampicin market.
- To identify and analyze the profile of leading
players operating in India rifampicin market.
- To identify key sustainable strategies adopted
by market players in India rifampicin market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of manufacturers across the globe. Subsequently, TechSci
Research conducted primary research surveys with the identified companies.
While interviewing, the respondents were also enquired about their competitors.
Through this technique, TechSci Research could include the manufacturers which
could not be identified due to the limitations of secondary research. TechSci
Research analyzed the manufacturers, distribution channels and presence of all
major players across the globe.
TechSci Research calculated the market size of India rifampicin market using a bottom-up approach, wherein data for various end-user
segments was recorded and forecast for the future years. TechSci Research
sourced these values from the industry experts and company representatives and
externally validated through analyzing historical data of these product types
and applications for getting an appropriate, overall market size. Various
secondary sources such as company websites, news articles, press releases,
company annual reports, investor presentations and financial reports were also studied
by TechSci Research.
Key Target Audience:
- Rifampicin manufacturers/
suppliers/ distributors
- Market research and
consulting firms
- Government bodies such as
regulating authorities and policy makers
- Organizations, forums and
alliances related to rifampicin
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers and partners, end users, etc., besides
allowing them in strategizing investments and capitalizing on market
opportunities.
Report Scope:
In this report, India rifampicin market has
been segmented into following categories, in addition to the industry trends
which have also been detailed below:
- India Rifampicin Market, By Source:
- In-house
- Contract Manufacturing Organizations
- India Rifampicin Market, By Form:
- Tablet
- Capsule
- Injections
- India Rifampicin Market, By Route of Administration:
- India Rifampicin Market, By Distribution Channel:
- India Rifampicin Market, By Application:
- Tuberculosis
- Leprosy
- Legionnaire's Disease
- Others
- India Rifampicin Market, By End User:
- India Rifampicin Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India rifampicin market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed
analysis and profiling of additional market players (up to five).
India rifampicin market is
an upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]